What blood tube for HbA1c testing is the correct choice? In UK clinical practice, the answer is the K2EDTA tube, identifiable by its purple or lavender-coloured cap. This anticoagulant tube preserves red blood cells and prevents clotting, both essential for accurate glycated haemoglobin measurement. HbA1c reflects average blood glucose control over two to three months and is central to diagnosing and monitoring diabetes under NICE guidance. Choosing the wrong tube can compromise results, delay diagnosis, and affect patient care. This article explains which tube to use, how to handle samples correctly, and how to avoid common pre-analytical errors.

Which Blood Collection Tube Is Used for HbA1c Testing

The K2EDTA tube, identified by its purple or lavender cap, is the standard blood collection tube for HbA1c testing in UK NHS laboratories, as EDTA preserves intact red blood cells required for accurate glycated haemoglobin measurement.

HbA1c (glycated haemoglobin) testing requires a specific type of blood collection tube to ensure accurate and reliable results. In the UK, the standard tube used for HbA1c testing is the K2EDTA (dipotassium ethylenediaminetetraacetic acid) tube, universally identified by its purple or lavender-coloured cap. EDTA acts as an anticoagulant by chelating calcium ions, preventing the blood sample from clotting and preserving the integrity of red blood cells — the very cells in which haemoglobin is measured.

The HbA1c test measures the proportion of haemoglobin that has been glycated (bound to glucose) over the preceding two to three months, reflecting average blood glucose control. Because this measurement depends on intact red blood cells, it is essential that the sample remains anticoagulated and unhaemolysed. The K2EDTA tube fulfils both requirements effectively and is the preferred and standard anticoagulant across NHS laboratories and point-of-care testing devices.

Although some HbA1c analysers may specify alternative anticoagulants in their instructions for use, most NHS laboratories will only accept K2EDTA (purple/lavender cap) samples. Lithium heparin (green cap) tubes are not standard for HbA1c testing in UK laboratories and are likely to be rejected unless your local laboratory explicitly states otherwise in its sample collection handbook. If you are unsure which tube your local laboratory requires, always consult the laboratory's sample collection handbook or contact the biochemistry department directly, as protocols can vary slightly between NHS trusts.

How HbA1c Samples Are Collected and Handled in the UK

HbA1c samples are collected by venepuncture into a K2EDTA tube without fasting, gently inverted 8–10 times, and stored at 2–8°C; HbA1c is unsuitable for diagnosis in certain groups, including children and pregnant women.

HbA1c blood samples are collected via a standard venepuncture procedure, typically from the antecubital fossa (the inner elbow). Unlike fasting glucose tests, HbA1c does not require the patient to fast beforehand, which makes it a more convenient and flexible test for both patients and clinicians. This is one reason NICE recommends HbA1c as the preferred diagnostic test for type 2 diabetes in most adults (NICE NG28).

However, HbA1c is not suitable for diagnosis in all situations. NICE NG28 specifies that HbA1c should not be used to diagnose diabetes in the following circumstances:

• Children and young people

• Pregnant women or those who are less than two months postpartum

• People with suspected type 1 diabetes or acute-onset hyperglycaemia

• People with conditions that affect red cell turnover (such as haemolytic anaemia, haemoglobin variants, or recent blood transfusion)

In these situations, plasma glucose measurements should be used instead. When HbA1c is used for diagnosis, a confirmatory laboratory venous EDTA sample is required — a point-of-care result alone is not sufficient to confirm a new diagnosis.

Once collected into the K2EDTA tube, the sample must be gently inverted 8–10 times immediately after collection (per tube manufacturer guidance) to ensure thorough mixing of the blood with the anticoagulant. Vigorous shaking should be avoided, as this can cause haemolysis — the rupture of red blood cells — which may compromise the result.

In terms of storage and transport, NHS guidelines generally recommend that HbA1c samples are:

• Stored at 2–8°C if not analysed immediately

• Processed within the stability window specified by your local laboratory — K2EDTA whole blood for HbA1c is commonly stable for up to seven days at 2–8°C, though this is method-dependent; always defer to your local laboratory handbook

• Kept away from temperature extremes, as improper storage conditions can affect HbA1c measurement

For point-of-care HbA1c testing — increasingly used in GP surgeries and diabetes clinics — a fingerprick capillary sample may be used instead of a venous sample. Devices such as the Afinion and Quo-Test analysers are CE/UKCA-marked in vitro diagnostic devices (IVDs) used for this purpose, subject to appropriate internal quality control and external quality assessment. However, venous K2EDTA samples sent to an accredited laboratory remain the reference standard for diagnostic purposes, in line with NICE NG28.

Why the Correct Tube Matters for Accurate HbA1c Results

Using the wrong tube — such as a serum or fluoride oxalate tube — destroys red blood cells or is analytically incompatible, rendering the sample unusable and risking clinically significant errors in diabetes diagnosis or management.

Using the correct blood collection tube is not merely a procedural formality — it has a direct impact on the clinical accuracy of the HbA1c result, which in turn influences diagnosis and treatment decisions for millions of people living with or at risk of diabetes in the UK.

If a serum tube (e.g., gold or red cap) is used instead of a K2EDTA tube, the blood will clot, destroying the red blood cells needed for analysis. This renders the sample completely unsuitable for HbA1c testing. Similarly, a fluoride oxalate tube (grey cap) — designed for glucose measurement — is not an accepted sample type for HbA1c in UK laboratories and will typically be rejected, as it is incompatible with the analytical methods used.

The consequences of an inaccurate HbA1c result can be clinically significant:

• A falsely elevated result may lead to unnecessary escalation of diabetes treatment, increasing the risk of hypoglycaemia

• A falsely low result may delay diagnosis or give false reassurance about glycaemic control

• Repeated incorrect samples cause delays in patient care and increase NHS laboratory costs

Certain patient-specific factors can also affect HbA1c accuracy regardless of tube type. These include haemoglobin variants (such as HbS or HbC), haemolytic anaemia, iron deficiency anaemia, and chronic kidney disease. The degree of interference is method-dependent; some analysers are designed to be variant-insensitive, and laboratories may add interpretative comments or use an alternative method when interference is suspected. In cases where HbA1c is considered unreliable, alternative markers such as fructosamine may be considered — though fructosamine reflects shorter-term glycaemic control (approximately two to three weeks) and is itself affected by albumin and protein levels. Clinicians should always interpret HbA1c results in the context of the patient's full clinical picture, as recommended by NICE NG28 and the Association for Clinical Biochemistry and Laboratory Medicine (ACB).

Common Errors in HbA1c Sample Collection and How to Avoid Them

The most common HbA1c pre-analytical errors include using the wrong tube, insufficient mixing, underfilling, delayed processing, and haemolysis; all are preventable by following local NHS trust phlebotomy SOPs and ensuring regular staff training.

Despite being a relatively straightforward test, HbA1c sample collection is subject to a number of common errors that can compromise result quality. Awareness of these pitfalls is important for all healthcare professionals involved in phlebotomy and sample processing.

The most frequently encountered errors include:

• Using the wrong tube — submitting a serum, citrate, or glucose tube instead of a K2EDTA tube is the most common pre-analytical error and will usually result in sample rejection

• Insufficient mixing — failing to invert the tube 8–10 times gently after collection can lead to micro-clot formation, causing sample rejection

• Underfilling the tube — K2EDTA tubes must be filled to the indicated line; underfilling alters the blood-to-anticoagulant ratio and may affect results

• Delayed processing or incorrect storage — delays or failure to store samples at the correct temperature may affect HbA1c measurement and lead to sample rejection; always adhere to your local laboratory's stated stability timelines

• Haemolysis — caused by excessive shaking, using a needle that is too small, or drawing blood too forcefully through the needle

To minimise these errors, healthcare professionals should follow their local NHS trust's phlebotomy standard operating procedures (SOPs) and ensure that all staff involved in sample collection receive regular, up-to-date training. Sample labelling must be completed at the bedside using at least two patient identifiers (for example, full name and date of birth), in line with UK patient and sample identification guidance from the National Patient Safety Agency (NPSA) and the Royal College of Pathologists (RCPath). Labelling errors are a patient safety concern and must be avoided.

If a sample is rejected by the laboratory, the requesting clinician will be notified and a repeat sample will be required. Patients should be reassured that a repeat test is a routine quality measure. If you are a patient with concerns about your HbA1c result or the testing process, speak to your GP or diabetes care team, who can advise on next steps and ensure the correct sample is obtained.

If you believe you have experienced a problem with a medical device used in your care, you can report this to the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

Frequently Asked Questions